Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women

NCT03854396 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped due to termination of ISR by PI with agreement by grant sponsor

Conditions

Recurrent Urinary Tract Infection
Postmenopause
Postmenopausal Syndrome
Postmenopausal Symptoms
Menopause

Interventions

DRUG: Prasterone
DRUG: Placebo

Sponsor

Olivia Cardenas-Trowers, M.D.

Collaborators

[object Object]